U.S. Tobacco Stock News

Genco Shipping & Trading (GNK) shares were in focus after the company released fourth quarter 2025 results, reporting higher quarterly revenue and net income. The company also reported a full year net loss and declared a cash dividend. See our latest analysis for Genco Shipping & Trading. Genco Shipping & Trading’s recent earnings and dividend update comes after a strong run in the market, with a 30 day share price return of 16.99% and a 1 year total shareholder return of 84.56%. This...

If you are wondering whether Summit Therapeutics is priced attractively or already expensive, you will want to understand how its current share price compares with different measures of underlying value. The stock recently closed at US$16.19, with returns of 0.6% over 7 days, 11.8% over 30 days, a 7.6% decline year to date, a 15.4% decline over 1 year, and a very large gain over 3 years and 189.1% over 5 years. Taken together, these figures point to a mix of past momentum and more recent...

Americold Realty Trust (NYSE:COLD) has agreed to acquire a temperature controlled facility in Houston, expanding its global footprint. The deal adds capacity in a key logistics hub that serves both domestic and international food supply chains. The company is integrating new technology across its network while working through operational challenges tied to customer contracts and concentration. Americold Realty Trust, listed as NYSE:COLD, focuses on temperature controlled warehouses and...

If you are trying to work out whether Full Truck Alliance is attractively priced or not, its current valuation metrics and what sits behind them are going to be the key things to focus on. The share price, last closing at US$9.32, has seen a 1.4% decline over the past week and is also down 5.9% over 30 days and 17.2% year to date, while the 3 year return sits at 17.2%. Recent news coverage has focused on Full Truck Alliance as a major digital freight platform in China and how it fits into...

Li Auto rolled out a major over the air update to its vehicle fleet ahead of the Chinese Spring Festival, upgrading its smart cockpit, VLA Driver large model, and smart electric features. The company supported more than 1.45 million charging sessions during the festival travel season through its charging network. Li Auto plans to launch a new Li L9 model in the coming quarter, adding to its flagship range. For investors tracking NasdaqGS:LI, these product and infrastructure updates come...

If you are wondering whether CDW is priced attractively today, it helps to step back and separate the share price story from the underlying value story. CDW closed at US$124.77, with a 1.3% gain over the last 7 days, a 1.3% decline over 30 days, a 6.3% decline year to date, and a 26.5% decline over the past year. The 3 and 5 year returns sit at 36.0% and 14.4% declines respectively. These moves have kept CDW on many investors' watchlists as they reassess how much risk they are taking on at...

Wave Life Sciences reported positive proof of concept for obesity candidate WVE-007 in Phase I, with fat loss and preservation of muscle mass. The company is preparing a pivotal Phase II trial for WVE-007 following these early clinical results. RNA editing candidates WVE-006 for alpha-1 antitrypsin deficiency and WVE-008 for liver disease are progressing toward key regulatory milestones. For investors tracking NasdaqGM:WVE, these updates come with a share price of $13.85 and a very large 3...

If you are wondering whether Middlesex Water at around US$54.55 is a bargain or just fairly priced, you are not alone, many investors are asking the same question. The stock has been fairly quiet over the last week with a 0.5% decline, but the 4.1% move over 30 days and 8.5% return year to date contrast with a 3.5% decline over 1 year and deeper 21.8% and 16.4% declines over 3 and 5 years. Recent attention on regulated utilities and their capital needs has kept investor focus on balance...

Why Douglas Dynamics (PLOW) is back on investors' radar Douglas Dynamics (PLOW) has drawn fresh attention after reporting fourth quarter 2025 earnings, issuing net sales guidance for 2026 between US$710 million and US$760 million, and affirming its quarterly dividend. See our latest analysis for Douglas Dynamics. The latest earnings release, 2026 net sales guidance and dividend affirmation come after a strong run in the shares, with a 30 day share price return of 24.44% and a 1 year total...

EPR Properties (NYSE:EPR) announced the retirement of Chief Investment Officer Gregory Zimmerman. Benjamin Fox has been appointed as the new CIO as part of the leadership transition. The company recently completed acquisitions in experiential real estate assets. EPR also approved a 5.1% dividend increase. EPR Properties, trading at $59.94, operates in the experiential net lease space. Its recent moves come after multi year share returns of 82.4% over 3 years and 73.6% over 5 years. In the...

In February 2026, Upwork Inc. announced that its Board of Directors had authorized an open-ended share repurchase program of up to US$300,000,000 of its common stock. This sizable buyback authorization highlights management’s current priorities for capital allocation, including potential effects on share count, cash deployment, and balance sheet flexibility. We’ll now examine how this new US$300,000,000 buyback program could influence Upwork’s existing investment narrative and longer-term...

Wondering whether DXC Technology at around US$12.19 is starting to look like a bargain or a value trap? This article walks through what the numbers actually say about the stock. The share price has had a mixed run, with a 2.9% return over the last 7 days, a 15.5% decline over 30 days, a 13.4% decline year to date, and a 32.7% decline over the past year. Over longer periods, the 3 year and 5 year returns sit at declines of 57.2% and 56.5% respectively. These moves have kept DXC Technology on...

If you are wondering whether Avnet at around US$64.98 is still offering value or starting to look fully priced, you are asking the right question for a stock that gets a lot of attention from value focused investors. The share price has been active recently, with a 3.4% decline over the last 7 days, a 4.2% return over 30 days, and longer term returns of 31.7% year to date, 35.8% over 1 year, 55.2% over 3 years, and 87.7% over 5 years. Recent coverage of Avnet has centered on its role as a...

DRDGOLD is progressing its Vision 2028 initiative, focused on infrastructure upgrades and operational improvements across its tailings operations. The company is moving ahead with plans to link processing plants and restart deposition at key tailings storage facilities. These developments are intended to support longer term operating plans and more efficient use of existing assets. For investors watching NYSE:DRD, the Vision 2028 work sits against a share price of $38.32 and multi year...

Multiple law firms have filed class action lawsuits against Richtech Robotics (NasdaqCM:RR) alleging the company misled investors about its relationship with Microsoft. The suits claim Richtech described a collaborative and commercial partnership with Microsoft, while Microsoft has reportedly denied having a commercial relationship. Investors are focusing on potential disclosure issues, legal exposure, and the impact of these claims on Richtech's credibility and future capital...

Carter's (NYSE:CRI) has reported its first year over year revenue growth since 2021, supported by stronger retail sales and demand creation efforts. The company plans to close about 150 lower margin stores by 2028 while expanding higher priced product assortments for Gen Z and Millennial families. Carter's is also putting more emphasis on direct to consumer channels as it adjusts to changing shopping habits and cost pressures. Carter's shares recently closed at $34.95, with the stock down...

Itron (NasdaqGS:ITRI) has completed a $700 million offering of convertible senior notes. The offering follows the company’s fourth quarter results, which were described as robust and above expectations. The transaction adds a sizable pool of capital that can influence Itron’s balance sheet and future investment decisions. Itron focuses on technology and services that help utilities and cities manage energy, water, and smart infrastructure. For investors watching the broader push toward grid...

The J. M. Smucker Company recently reported fiscal 2026 third-quarter results showing higher net sales of US$2,339.4 million but a larger net loss of US$724.2 million, alongside slightly narrowed full-year net sales guidance of 3.5% to 4.0% growth and projected diluted EPS in the range of US$1.89 to US$1.39 loss. At the same time, Smucker moved to strengthen its governance and product portfolio by adding two financially experienced independent directors following engagement with Elliott...

If you are wondering whether MSCI is fairly priced or offering an opportunity right now, it helps to step back and look closely at what the current share price really reflects. The stock last closed at US$573.88, with recent returns of 6.6% over 7 days, a 5.8% decline over 30 days, 1.5% year to date, a 1.2% decline over 1 year, 9.6% over 3 years and 50.4% over 5 years. Taken together, these figures give a mixed picture of recent momentum and risk sentiment. Recent news around MSCI has...

If you are wondering whether Supernus Pharmaceuticals at around US$55.09 is still offering value after its recent run, you are not alone. The stock has posted returns of 8.7% over the past 7 days, 14.4% over 30 days, 11.4% year to date and 73.6% over 1 year, with longer term returns of 43.5% over 3 years and 116.0% over 5 years. These moves sit against a backdrop of continuing interest in Supernus Pharmaceuticals as a neurology focused drug maker. Investors are paying close attention to how...

Danaos (DAC) has just filed an omnibus shelf registration, covering potential offerings of common and preferred stock, debt securities, warrants and other instruments, a move that gives management broad future financing flexibility. See our latest analysis for Danaos. The shelf registration comes after a strong run in the shares, with a 7 day share price return of 8.95% and a year to date share price return of 24.18%. The 1 year total shareholder return of 58.92% and 5 year total shareholder...

If you are wondering whether V2X at around US$70.97 is still offering value or already pricing in a lot of optimism, you are not alone. The stock has returned 4.5% over the last 7 days, 3.1% over the last month, 27.7% year to date and 55.0% over the past year, which naturally raises questions about what is already baked into the current price. Recent coverage has focused on V2X as a capital goods company listed on the NYSE under the ticker VVX. Investors are paying close attention to how it...

If you are wondering whether TransDigm Group's current share price fairly reflects the business, this article is designed to help you think through that question step by step. The stock last closed at US$1,316.26, with returns of 1.6% over 7 days, a 7.8% decline over 30 days, a 3.1% decline year to date, 2.6% over 1 year, 99.9% over 3 years and 161.2% over 5 years. Recent share price moves sit against a backdrop of ongoing interest in TransDigm Group as a major US capital goods name...

If you are looking at Medical Properties Trust and wondering whether the current share price reflects its underlying worth, you are not alone. The stock closed at US$5.65 recently, with returns of 12.5% over the last 30 days, 11.2% year to date and 4.4% over the past year, set against longer term 3 year and 5 year returns of 28.9% and 60.3% declines. Recent headlines around Medical Properties Trust have focused on its balance sheet, portfolio repositioning and how it is responding to a...